Krystal Biotech Files 8-K
Ticker: KRYS · Form: 8-K · Filed: Jun 2, 2025 · CIK: 1711279
| Field | Detail |
|---|---|
| Company | Krystal Biotech, Inc. (KRYS) |
| Form Type | 8-K |
| Filed Date | Jun 2, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: disclosure, regulatory-filing
Related Tickers: KRYS
TL;DR
Krystal Biotech filed an 8-K, but details are scarce.
AI Summary
Krystal Biotech, Inc. filed an 8-K on June 2, 2025, to report other events. The filing does not contain specific details about the nature of these events, dollar amounts, or other named entities beyond the company itself.
Why It Matters
This filing indicates a material event has occurred for Krystal Biotech, Inc., requiring disclosure to investors, though the specifics are not yet detailed.
Risk Assessment
Risk Level: low — The filing is a standard disclosure form without immediate negative or positive financial implications detailed within the provided text.
Key Players & Entities
- Krystal Biotech, Inc. (company) — Registrant
FAQ
What specific event prompted Krystal Biotech, Inc. to file this 8-K on June 2, 2025?
The provided text of the 8-K filing does not specify the exact event that triggered the filing, only that it pertains to 'Other Events'.
Are there any financial figures or dollar amounts mentioned in this 8-K filing?
No, the provided text of the 8-K filing does not contain any specific financial figures or dollar amounts.
Does the filing mention any other companies or individuals involved in the reported event?
No, the provided text of the 8-K filing only explicitly names Krystal Biotech, Inc. and does not mention any other entities.
What is the principal executive office address for Krystal Biotech, Inc. as stated in the filing?
The principal executive offices are located at 2100 Wharton Street, Suite 701, Pittsburgh, Pennsylvania 15203.
Under which section of the Securities Exchange Act of 1934 is this 8-K report filed?
This 8-K report is filed pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 2, 2025 regarding Krystal Biotech, Inc. (KRYS).